Browse the detailed record of transactions filed by 김윤신, Chief Executive Officer. Officer active across 2 companies, notably 엑셀세라퓨틱스. Cumulatively, 17,943 filings have been logged. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Kim Yoon-shin is the General Manager at Excel Therapeutics, a company active in the biotechnology sector. He oversees the company's operations and is involved in strategic planning to ensure its success and growth.